Clinical Trial Update: Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients [NA]

View source ↗

Summary

The trial evaluating a calcineurin inhibitor-free, steroid-free immunosuppressive regimen for simultaneous islet-kidney transplantation in uremic Type 1 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1 | NA | Status: WITHDRAWN